期刊文献+

左室舒张功能不全对非瓣膜性持续性心房颤动患者左心耳血栓形成的影响 被引量:5

下载PDF
导出
摘要 目的研究左室舒张功能不全(LVDD)对非瓣膜性持续性心房颤动(PAF)患者左心耳血栓形成的影响。方法选择2013年2月至2014年2月在该院实施超声心动图诊断的非瓣膜性PAF患者100例,另选同期50例体检志愿者作为对照组。根据超声心动图所示的左心耳血栓情况将100例非瓣膜性PAF患者分成PAF有血栓组(48例)以及PAF无血栓组(52例)。所有受试者均通过Philips IE33型彩超仪经食管及经胸实施超声心动图诊断。对比各组患者超声心动图的检查结果,并进行PAF合并左心耳血栓相关因素的Logistic回归分析。结果 PAF有血栓组的E水平显著高于对照组,但低于PAF无血栓组;Ea-sep、Ea-lat、Em及LVEF水平均显著低于对照组以及PAF无血栓组,E/Em水平显著高于PAF无血栓组以及对照组水平(均P<0.05)。将PAF合并左心耳血栓作为因变量,将E、Ea-sep、Ea-lat、Em、E/Em、LAD及LVEF作为自变量进行Logistic回归分析,显示E/Em为PAF合并左心耳血栓的危险因素。结论 LVDD对非瓣膜性PAF并发左心耳血栓具有一定的影响,临床治疗应予以重视。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2014年第23期6567-6569,共3页 Chinese Journal of Gerontology
  • 相关文献

参考文献5

二级参考文献45

共引文献39

同被引文献60

  • 1王云书.C反应蛋白升高与心房颤动关系的探讨[J].中华全科医师杂志,2006,5(9):565-566. 被引量:3
  • 2Gariani K, Delabays A, Pemeger TV, et al. Use of brain natriuretie peptide to detect previously unknown left ventricular dysfunction in pa- tients with acute exacerbation of chronic obstructive pulmonary disease [ J]. Swiss Med Wkly, 2011,9( 141 ) :w13298.
  • 3Weir RA, Mcmurray JJ, Puu M, et al. Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure al- ready receiving an angiatensin - converting inhibitor plus aldosterone an- tagonist, with or without a beta blocker findings from the candesartan in heart failure assessment of reduction in mortality and morbidity[ J]. Eur J Heart Fail, 2008,10(2) :157 -163.
  • 4Kamano C, Osawa H, Hashimoto K, et al. N -Terminal pro -brain natriuretic peptide as a predictor of heart failure withpreserved ejection fraction in hemodialysis patients without fluid overload[J]. Blood Purif, 2012,33(1 -3) :37 -43.
  • 5Maeabaseo - OConnell A, Meymandi S, Bryg R. B - type natriuretic peptide (BNP) is useful in detecting asymptomatic left ventricular dys- function in low -income, uninsured patients [J]. Biol Res Nurs, 2010, 11(3) :280-287.
  • 6Porapakkham P, Porapakkham P, Zimmet H, et al. B -type natriuretic peptide - guided heart failure therapy: a meta - analysis [ J ]. Arch In- tern Med, 2010,170(6) :507 -514.
  • 7Alli O, Doshi S, Kar S,et al. Quality of life assessment in the random- ized PROTECT AF ( Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fi- brillation[ Jl. J Am Coil Cardiol, 2013, 61 (17) : 1790-1798.
  • 8Biering-Sorensen T, Mogelvang R, PedersenS, et al. Usefulness of the- myocardial performance index determined by tissue Doppler imaging m- mode for predicting mortality in the general population[J]. Am J Cardi- ol,2011,107(3) :478-483.
  • 9Di Blase L, Burkhardt JD, Mohanty P, et al. Left atrial appendage:an underrecognised trigger site of atrial fibrillation [ J ]. Circulation, 2010, 122(2) :109-118.
  • 10Urena M, Rodes-Cabau J, Freixa X, et al. Percutaneous left atrial ap- pendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagula- tion therapy[J]. J Am Coil Cardiol, 2013, 62(2) : 96-102.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部